Search results :

Bosutinib

More information: STITCH, PubChem and possibly Wikipedia

ATC Codes: None found

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2
Diarrhoea 9.1% - 82% x x
Nausea 42.1% - 46% x x
Thrombocytopenia 25.4% - 41% x x
Vomiting 37.1% - 39% x x
Abdominal pain 33.4% - 37% x x
Rash 6.1% - 35% x x
Anaemia 12.3% - 27.4% x x
Body temperature increased 23.4% - 26% x x
Fatigue 24% x x
Neutropenia 11.5% x x
Alanine aminotransferase increased 10.2% x x
Lipase increased 5.2% x
Aspartate aminotransferase increased 5% x x
Pancreatitis acute x x
Agranulocytosis x
Anaphylactic shock x x
Arthralgia 0% x x
Asthenia x x
Back pain x x
Bronchitis x x
Bronchopneumonia x
Chest pain x x
Infection x x
Connective tissue disorder x x
Cough 0% x x
Dehydration x x
Drug eruption x x
Dizziness 0% x x
Drug hypersensitivity x x
Dysgeusia x x
Dyspnoea x x
Oedema x x
Erythema multiforme x x
Gastritis x x
Gastrointestinal disorder x x
Gastrointestinal haemorrhage x x
Headache x x
Cardiac disorder x x
Hepatitis toxic x
Hyperkalaemia x x
Pulmonary hypertension x x
Immune system disorder x x
Influenza x x
Renal failure acute x x
Acute lymphocytic leukaemia x x
Leukopenia x
Long QT syndrome x
Mediastinal disorder x x
Nasopharyngitis 0% x x
Nervous system disorder x x
Pain x x
Pericardial effusion x x
Pericarditis x x
Pleural effusion x x
Pneumonia x x
Lobar pneumonia x
Prurigo x
Pruritus 0% x x
Renal failure x x
Respiratory tract infection 0% x x
Tinnitus x x
Upper gastrointestinal haemorrhage x
Upper respiratory tract infection x
Urinary tract disorder x x
Urticaria x x
Oedema peripheral x
Hypophosphataemia x
Hepatic function abnormal x
Lower respiratory tract infection x
Gamma-glutamyltransferase increased x
Electrocardiogram QT prolonged x x
Acute pulmonary oedema x x
Liver injury x x
Malnutrition x x
Unspecified disorder of skin and subcutaneous tissue x
Rash macular x
Malaise x
Myalgia x x
Decreased appetite 0% x x
Abdominal discomfort x
Abdominal pain upper x
Abdominal pain lower x
Abdominal tenderness x
Gastric haemorrhage x
Hepatotoxicity x x
Blood creatinine increased x x
Chest discomfort x
Hepatobiliary disease x x
Fluid retention x
Blood bilirubin increased x
Viral upper respiratory tract infection x
Rash maculo-papular x
Rash generalised x
Face oedema x
Gastrointestinal pain x
Acne x
Febrile neutropenia x x
Infestation NOS x x
Blood and lymphatic system disorders x x
Ear and labyrinth disorders x x
Blood amylase increased x
Blood creatine phosphokinase increased x x
Myelosuppression x
Respiratory tract infection viral x
Cytolytic hepatitis x
Gastrointestinal toxicity x
Respiratory failure x x
Atypical pneumonia x
Rash papular x
Renal impairment x
Exfoliative rash x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

BOSUTINIB

Side effects:74
Source:FDA Structured Product Label

bosutinib / bosutinib (as monohydrate)

Side effects:108
Source:EMA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label